Evidence map›Paper›PMID 36454826›Full record

ArticleScience (New York, N.Y.)2022

Active DNA demethylation promotes cell fate specification and the DNA damage response.

Dongpeng Wang, Wei Wu, Elsa Callen, Raphael Pavani, Nicholas Zolnerowich, Srikanth Kodali, Dali Zong, Nancy Wong, Santiago Noriega, William J Nathan and 8 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. 8-Oxoguanine: A Lesion, an Epigenetic Mark, or a Molecular Signal?International journal of molecular sciences · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Dongpeng Wang *Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0002-8272-1228
Wei Wu *Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0001-5164-2765
Elsa Callen *Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0002-6325-0221
Raphael PavaniLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0002-7187-2995
Nicholas ZolnerowichLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0003-0033-4003
Srikanth KodaliStem Cells and Regenerative Medicine, Center for Cell and Gene Therapy, Department of Molecular and Cellular Biology and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-9330-9880
Dali ZongLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.
Nancy WongLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0003-0696-5949
Santiago NoriegaLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.
William J NathanLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0003-2752-7630
Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0003-4085-7810
Raj ChariGenome Modification Core, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.ORCID 0000-0002-2216-313X
Michael J KruhlakLaboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
Ferenc LivakLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0003-2833-585X
Michael WardNational Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.ORCID 0000-0002-5296-8051
Keith CaldecottGenome Damage and Stability Centre, University of Sussex, Falmer Brighton, UK.ORCID 0000-0003-4255-9016
Bruno Di StefanoStem Cells and Regenerative Medicine, Center for Cell and Gene Therapy, Department of Molecular and Cellular Biology and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-2532-3087
André NussenzweigLaboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA.ORCID 0000-0002-8952-7268
National Human Genome Research Institute · USThe University of Texas MD Anderson Cancer Center · USChinese Academy of Sciences · CNFrederick National Laboratory for Cancer Research · USNational Cancer Institute · USNational Institute of Neurological Disorders and Stroke · USUniversity of Sussex · GB

Funding

Relationship between DNA damage detection and signalingZIABC010959 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSENZWEIG, ANDRE A. · 2009 to 2025
$27.0M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
DEFINING THE ROLE OF RNA SEQUESTRATION IN MAMMALIAN CELL FATER35GM147126 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Bruno Di Stefano · 2022 to 2026
$2.0M
Intramural NIH HHS ZIA BC010959NCI NIH HHS HHSN261201000031CNCI NIH HHS HHSN261201500001CNCI NIH HHS HHSN261201500001GNCI NIH HHS HHSN261201500001WNCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INIDDK NIH HHS T32 DK060445NIGMS NIH HHS R35 GM147126
6 · The paper itself

Abstract

Neurons harbor high levels of single-strand DNA breaks (SSBs) that are targeted to neuronal enhancers, but the source of this endogenous damage remains unclear. Using two systems of postmitotic lineage specification-induced pluripotent stem cell-derived neurons and transdifferentiated macrophages-we show that thymidine DNA glycosylase (TDG)-driven excision of methylcytosines oxidized with ten-eleven translocation enzymes (TET) is a source of SSBs. Although macrophage differentiation favors short-patch base excision repair to fill in single-nucleotide gaps, neurons also frequently use the long-patch subpathway. Disrupting this gap-filling process using anti-neoplastic cytosine analogs triggers a DNA damage response and neuronal cell death, which is dependent on TDG. Thus, TET-mediated active DNA demethylation promotes endogenous DNA damage, a process that normally safeguards cell identity but can also provoke neurotoxicity after anticancer treatments.

Indexed as

DNA Breaks, Single-StrandedDNA DemethylationDNA RepairEnhancer Elements, GeneticInduced Pluripotent Stem CellsNeuronsThymine DNA Glycosylase5-MethylcytosineCell DifferentiationCell TransdifferentiationHumans5-MethylcytosineThymine DNA Glycosylase

Identifiers

PMID36454826
PMCPMC10196940
OpenAlexW4310700336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.